首页> 外文期刊>Circulation journal >Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease – 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 –
【24h】

Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease – 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 –

机译:无保护的左主干冠状动脉疾病经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较– CREDO-Kyoto PCI / CABG注册组2的5年结果–

获取原文
           

摘要

Background: Studies evaluating long-term (≥5 years) outcome of percutaneous coronary intervention (PCI) compared with coronary artery bypass grafting (CABG) in patients with unprotected left main coronary artery disease (ULMCAD) are still limited, despite concerns for late adverse events after drug-eluting stents implantation. Methods?and?Results: We identified 1,004 patients with ULMCAD (PCI: n=364, CABG: n=640) among 15,939 patients with first coronary revascularization enrolled in the CREDO-Kyoto PCI/CABG registry cohort-2. The primary outcome measure in the current analysis was a composite of death, myocardial infarction, and stroke (death/MI/stroke). The cumulative 5-year incidence of and the adjusted risk for death/MI/stroke were significantly higher in the PCI group than in the CABG group (34.5% vs. 24.1%, log-rank P
机译:背景:尽管担心晚期不良反应,但评估无保护的左主冠状动脉疾病(ULMCAD)患者的经皮冠状动脉介入治疗(PCI)与冠状动脉旁路移植术(CABG)相比,长期(≥5年)结局的研究仍然有限药物洗脱支架植入后发生的事件。方法和结果:我们在参加CREDO-Kyoto PCI / CABG登记队列2的15939例首次冠状动脉血运重建患者中,确定了1004例ULMCAD(PCI:n = 364,CABG:n = 640)。当前分析中的主要结局指标是死亡,心肌梗塞和中风(死亡/ MI /中风)的综合指标。 PCI组的5年累积发生率和死亡/ MI /中风的调整风险显着高于CABG组(分别为34.5%和24.1%,对数秩P

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号